Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study.

Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1385-91. doi: 10.1161/ATVBAHA.107.157164. Epub 2008 Apr 10.

2.

C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.

Buckley DI, Fu R, Freeman M, Rogers K, Helfand M.

Ann Intern Med. 2009 Oct 6;151(7):483-95. Review.

PMID:
19805771
3.

[C-reactive protein in patients with coronary heart disease].

Rajtar R, Kolasińska-Kloch W, Kloch M.

Folia Med Cracov. 2004;45(1-2):25-32. Review. Polish.

PMID:
16276823
4.
5.

[Inflammation and C-reactive protein in cardiovascular disease].

Munk PS, Larsen AI.

Tidsskr Nor Laegeforen. 2009 Jun 11;129(12):1221-4. doi: 10.4045/tidsskr.08.0011. Review. Norwegian.

6.

High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease.

Mitra B, Panja M.

J Assoc Physicians India. 2005 Jan;53:25-32. Review.

PMID:
15857009
7.

Impact of C-reactive protein on disease risk and its relation to dietary factors.

Nanri A, Moore MA, Kono S.

Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):167-77. Review.

8.

Interrelationships between inflammation, C-reactive protein, and insulin resistance.

Ndumele CE, Pradhan AD, Ridker PM.

J Cardiometab Syndr. 2006 Summer;1(3):190-6. Review.

9.
10.

Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke.

Ueshima H.

J Atheroscler Thromb. 2007 Dec;14(6):278-86. Epub 2007 Dec 17. Review.

11.

C-reactive protein, inflammation, and coronary risk.

Ridker PM, Morrow DA.

Cardiol Clin. 2003 Aug;21(3):315-25. Review.

PMID:
14621448
12.

[High sensitivity of C-reactive protein in primary prevention].

Corrado E, Novo S.

G Ital Cardiol (Rome). 2007 Jun;8(6):327-34. Review. Italian.

PMID:
17633905
13.

High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease.

Rosenson RS, Koenig W.

Curr Opin Cardiol. 2002 Jul;17(4):325-31. Review.

PMID:
12151864
14.

High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment.

Benzaquen LR, Yu H, Rifai N.

Crit Rev Clin Lab Sci. 2002 Sep;39(4-5):459-97. Review.

PMID:
12385503
15.

[C-reactive protein: cardiovascular issues of an acute-phase protein].

Amezcua-Guerra LM, Springall del Villar R, Bojalil Parra R.

Arch Cardiol Mex. 2007 Jan-Mar;77(1):58-66. Review. Spanish.

PMID:
17500194
16.

[C-reactive protein potential risk factor for cardiovascular disease].

Tornvall P, Pernow J, Hansson LO.

Lakartidningen. 2003 Aug 28;100(35):2691-3. Review. Swedish.

PMID:
14531129
17.

[C-reactive protein in cardiovascular risk evaluation].

Fabijanić D, Banić M, Kardum D.

Lijec Vjesn. 2006 May-Jun;128(5-6):167-74. Review. Croatian.

PMID:
16910418
18.

Clinical implications of C-reactive protein as a predictor of vascular risk.

Katrinchak C, Fritz K.

J Am Acad Nurse Pract. 2007 Jul;19(7):335-40. Review.

PMID:
17680898
19.
20.

Screening for heart disease: C-reactive protein versus coronary artery calcium.

Patel AA, Budoff MJ.

Expert Rev Cardiovasc Ther. 2010 Jan;8(1):125-31. doi: 10.1586/erc.09.166. Review.

PMID:
20014938
Items per page

Supplemental Content

Write to the Help Desk